@valotx.com
Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Valo Therapeutics (ValoTx) is a pioneering brand that specializes in immunotherapy for cancer treatment. As a spin-out company from the renowned IVTLab at the University of Helsinki, Finland, ValoTx brings together a team of highly skilled and experienced experts in oncolytic virus and immunotherapy. What sets ValoTx apart is their patented technology, which combines the best features of different clinically proven immunotherapy concepts.
With their unique technology platform, they can deliver various disease-targeting peptides onto the surface of oncolytic vectors, such as adenoviruses, enveloped viruses, and bacteria. This innovative approach triggers an enhanced T-cell driven immune response that effectively destroys targeted tumors. ValoTx's technology allows for the rapid creation of multiple vector-based immunotherapies without the need for genetically engineering the vectors.
By leveraging electrostatic interactions and membrane penetrating peptides, they can easily and quickly combine disease-associated peptides with the vectors. With the goal of transforming the field of immunotherapy in cancer, Valo Therapeutics is dedicated to developing groundbreaking treatments that promise to provide lasting improvements in patient outcomes
Company Type
Privately Held
Company Size
11-50
Year Founded
2016
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories